Inogen Inc (INGN) stock
INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 12/3068% below fair value
$5.69+0.07 (+1.25%)
Close on Nov 13, 2026Market cap $151.00MP/E –Yield –
Inogen EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Inogen's EV/EBITDA was 160.8× on Oct 31, 2022, against 36.7× a year earlier. Over the last 5 years it ranged from 10.7× to 567.9×, with a median of 41.2×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Oct 31, 2022 | 160.8× | +141.2 |
| 2021 | Dec 31, 2021 | 19.7× | −375.4 |
| 2020 | Dec 31, 2020 | 395.1× | +362.7 |
| 2019 | Dec 31, 2019 | 32.3× | −17.3 |
| 2018 | Dec 31, 2018 | 49.7× | −7.1 |
| 2017 | Dec 29, 2017 | 56.8× | +19.9 |
| 2016 | Dec 30, 2016 | 36.9× | +10.3 |
| 2015 | Dec 31, 2015 | 26.6× | +1.6 |
| 2014 | Dec 31, 2014 | 25.0× | – |
See a number that looks wrong?